Robert J. Mulroy - Net Worth and Insider Trading
Robert J. Mulroy Net Worth
The estimated net worth of Robert J. Mulroy is at least $3 Million dollars as of 2024-09-21. Robert J. Mulroy is the President and CEO of Merrimack Pharmaceuticals Inc and owns about 168,333 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $3 Million. Details can be seen in Robert J. Mulroy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert J. Mulroy has not made any transactions after 2015-03-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert J. Mulroy
Robert J. Mulroy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert J. Mulroy owns 1 companies in total, including Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of Robert J. Mulroy’s form 4 insider trades.
Insider Ownership Summary of Robert J. Mulroy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2015-03-24 | director & President and CEO |
Robert J. Mulroy Latest Holdings Summary
Robert J. Mulroy currently owns a total of 1 stock. Robert J. Mulroy owns 168,333 shares of Merrimack Pharmaceuticals Inc (MACK) as of March 24, 2015, with a value of $3 Million.
Latest Holdings of Robert J. Mulroy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2015-03-24 | 168,333 | 15.13 | 2,546,878 |
Holding Weightings of Robert J. Mulroy
Robert J. Mulroy Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert J. Mulroy has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the sale of 11,437 shares on March 24, 2015, which brought Robert J. Mulroy around $1 Million.
Insider Trading History of Robert J. Mulroy
- 1
Robert J. Mulroy Trading Performance
Robert J. Mulroy Ownership Network
Robert J. Mulroy Owned Company Details
What does Merrimack Pharmaceuticals Inc do?
Who are the key executives at Merrimack Pharmaceuticals Inc?
Robert J. Mulroy is the director & President and CEO of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .
Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary
Over the past 18 months, Robert J. Mulroy made no insider transaction in Merrimack Pharmaceuticals Inc (MACK). Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 446,418 shares made by Eric Andersen , and a net purchase of 4,000 shares made by Gary L Crocker .
In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 450,418 shares were bought by its insiders, resulting in a net purchase of 450,418 shares.
Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merrimack Pharmaceuticals Inc Insider Transactions
Robert J. Mulroy Mailing Address
Above is the net worth, insider trading, and ownership report for Robert J. Mulroy. You might contact Robert J. Mulroy via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
